169 related articles for article (PubMed ID: 36225783)
21. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
23. Visualized machine learning models combined with propensity score matching analysis in single PR-positive breast cancer prognosis: a multicenter population-based study.
Li C; Hui Y; Wei X; Yao P; Jia Y; Liu M; Wang Y; Li J; Cai Y; Zhang Y; Feng Z; Zhang Y; Zhang S; Du C
Am J Cancer Res; 2023; 13(6):2234-2253. PubMed ID: 37424799
[TBL] [Abstract][Full Text] [Related]
24. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
26. An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm.
Huang Z; Hu C; Chi C; Jiang Z; Tong Y; Zhao C
Biomed Res Int; 2020; 2020():3462363. PubMed ID: 32685470
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation.
Zhao H; Li W; Li X; Ding Z; Zhao S
J Thorac Dis; 2022 Dec; 14(12):4877-4893. PubMed ID: 36647503
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases.
Parkes A; Warneke CL; Clifton K; Al-Awadhi A; Oke O; Pestana RC; Alhalabi O; Litton JK; Hortobagyi GN
Oncologist; 2018 Nov; 23(11):1282-1288. PubMed ID: 30120166
[TBL] [Abstract][Full Text] [Related]
29. Local Ablative Treatment Improves Survival in ESCC Patients With Specific Metastases, 2010-2016: A Population-Based SEER Analysis.
Yang H; Wang K; Li Y; Li S; Yuan L; Ge H
Front Oncol; 2022; 12():783752. PubMed ID: 35785182
[TBL] [Abstract][Full Text] [Related]
30. Impact of surgery on survival in breast cancer with bone metastases only: a SEER database retrospective analysis.
Peng P; Chen JY; Han YT; Chen X; Li HY; Hu CH; Wang JL
BMC Surg; 2021 Oct; 21(1):378. PubMed ID: 34702227
[TBL] [Abstract][Full Text] [Related]
31. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract][Full Text] [Related]
32. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
33. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.
Niikura N; Liu J; Hayashi N; Palla SL; Tokuda Y; Hortobagyi GN; Ueno NT; Theriault RL
Oncologist; 2011; 16(2):155-64. PubMed ID: 21266401
[TBL] [Abstract][Full Text] [Related]
36. Behavior of metastatic breast cancer according to subtype.
Van Mechelen M; Van Herck A; Punie K; Nevelsteen I; Smeets A; Neven P; Weltens C; Han S; Vanderstichele A; Floris G; Lobelle JP; Wildiers H
Breast Cancer Res Treat; 2020 May; 181(1):115-125. PubMed ID: 32193802
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients.
Zhao F; Wang J; Yu H; Cheng X; Li X; Zhu X; Xu X; Lin J; Chen X; Yan S
Radiat Oncol; 2020 Feb; 15(1):49. PubMed ID: 32103755
[TBL] [Abstract][Full Text] [Related]
38. Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot S; Pijl H; Charehbili A; van de Ven S; Smit VTHBM; Meershoek-Klein Kranenbarg E; Heijns JB; van Warmerdam LJC; Kessels LW; Dercksen MW; Pepels MJAE; van Laarhoven HWM; Vriens BEPJ; Putter H; Fiocco M; Liefers GJ; van der Hoeven JJM; Nortier JWR; Kroep JR;
Breast Cancer Res; 2019 Aug; 21(1):97. PubMed ID: 31455425
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
40. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.
Errani C; Cosentino M; Ciani G; Ferra L; Alfaro PA; Bordini B; Donati DM
Int Orthop; 2021 May; 45(5):1337-1346. PubMed ID: 33392682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
